Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia.Published in:OncoTargets & Therapy, 2017, v. 10, p. 645, doi. 10.2147/OTT.S102646By:Huber, Henriette;Edenhofer, Simone;Estenfelder, Sven;Stilgenbauer, StephanPublication type:Article
Bevacizumab in temozolomide refractory high-grade gliomas: single-centre experience and review of the literature.Published in:Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756285617753597By:Jeck, Jennifer;Kassubek, Rebecca;Coburger, Jan;Edenhofer, Simone;Schönsteiner, Stefan S.;Ludolph, Albert C.;Schmitz, Bernd;Engelke, Jens;Mayer-Steinacker, Regine;Lewerenz, Jan;Bullinger, LarsPublication type:Article